Publikationen 2012

Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum
A, Pilz G, Nothnagel D, Steen H, Petersen S, Nagel E,
Prasad S, Schumm J, Greulich S, Cagnolo A, Monney P,
Deluigi CC, Dill T, Frank H, Sabin G, Schneider S, Mahrholdt H.
European cardiovascular magnetic resonance (EuroCMR)
registry - multi national results from 57 centers
in 15 countries. J Cardiovasc Magn Reson. 2013 Jan
18;15:9. doi: 10.1186/1532-429X-15-9.

Nassenstein K, Orzada S, Haering L, Czylwik A, Jensen C,
Schlosser T, Bruder O, Ladd ME, Maderwald S.
Cardiac magnetic resonance: is phonocardiogram gating
reliable in velocity-encoded phase contrast imaging?
Eur Radiol. 2012 Dec;22(12):2679-87. doi: 10.1007/
s00330-012-2547-6. Epub 2012 Jul 10.

Greulich S, Schumm J, Grün S, Bruder O, Sechtem U,
Mahrholdt H.
Incremental value of late gadolinium enhancement for
management of patients with hypertrophic cardiomyopathy.
Am J Cardiol. 2012 Oct 15;110(8):1207-12. doi: 10.1016/j.
amjcard.2012.05.064. Epub 2012 Jul 3.

Greulich S, Bruder O, Parker M, Schumm J, Grün S,
Schneider S, Klem I, Sechtem U, Mahrholdt H.
Comparison of exercise electrocardiography and stress
perfusion CMR for the detection of coronary artery disease
in women.
J Cardiovasc Magn Reson. 2012 Jun 14;14:36. doi:
10.1186/1532-429X-14-36.

Moschetti K, Muzzarelli S, Pinget C, Wagner A, Pilz G,
Wasserfallen JB, Schulz-Menger J, Nothnagel D, Dill T,
Frank H, Lombardi M, Bruder O, Mahrholdt H, Schwitter J.
Cost evaluation of cardiovascular magnetic resonance
versus coronary angiography for the diagnostic workup
of coronary artery disease: application of the European
Cardiovascular Magnetic Resonance registry data
to the German, United Kingdom, Swiss, and United States
health care systems.
J Cardiovasc Magn Reson. 2012 Jun 14;14:35. doi:

Grün S, Schumm J, Greulich S, Wagner A, Schneider
S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf
R, Sechtem U, Mahrholdt H.
Long-term follow-up of biopsy-proven viral myocarditis:
predictors of mortality and incomplete recovery.
J Am Coll Cardiol. 2012 May 1;59(18):1604-15. doi:
10.1016/j.jacc.2012.01.007. Epub 2012 Feb 22.

Bruder O, Schneider S, Nothnagel D, Pilz G, Lombardi M,
Sinha A, Wagner A, Dill T, Frank H, van Rossum A, Schwitter
J, Nagel E, Senges J, Sabin G, Sechtem U, Mahrholdt
H.
Acute adverse reactions to gadolinium-based contrast
agents in CMR: multicenter experience with 17,767 patients
from the EuroCMR Registry.
JACC Cardiovasc Imaging. 2011 Nov;4(11):1171-6. doi:
10.1016/j.jcmg.2011.06.019.

Nassenstein K, Orzada S, Haering L, Czylwik A, Zenge
M, Eberle H, Schlosser T, Bruder O, Müller E, Ladd ME,
Maderwald S.
Cardiac MRI: evaluation of phonocardiogram-gated
cine imaging for the assessment of global und regional
left ventricular function in clinical routine.
Eur Radiol. 2012 Mar;22(3):559-68. doi: 10.1007/s00330-
011-2279-z. Epub 2011 Sep 24.

Kniemeyer HW, Voshege M, Soliman A, Abu Al Nasr TM,
Beckmann H, Edelmann M.
Late spontaneous recanalization of a symptomatically
occluded internal carotid artery two years after extraintracranial
bypass. Case report and review of the literature.
J Cardiovasc Surg (Torino). 2012 Apr;53(2):241-6.

Prendergast BD, Naber CK, Popma JJ.
Transatlantic perspectives on TAVI: from essential infrastructure
and integration to expansion, research and
development.
Heart. 2012 Nov;98 Suppl 4:iv37-43. doi: 10.1136/
heartjnl-2012-302397. Review. No abstract available.

Buellesfeld L, Gerckens U, Erbel R, Zahn R, Linke A, Sievert
H, Figulla HR, Kuck KH, Hauptmann KE, Hambrecht
R, Richardt G, Naber C, Voehringer M, Mudra H, Senges J,
Grube E; German TAVI Registry Investigators.
Age-stratified baseline and outcome characteristics of
patients undergoing transcatheter aortic valve implantation:
results from the German multicenter registry.
J Invasive Cardiol. 2012 Oct;24(10):531-6.

Hehrlein C, Dietz U, Kubica J, Jørgensen E, Hoffmann
E, Naber C, Lesiak M, Schneider H, Wiemer M, Tölg R,
Richardt G.
Twelve-month results of a paclitaxel releasing balloon
in patients presenting with in-stent restenosis First-in-
Man (PEPPER) trial.
Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):260-4. doi:
10.1016/j.carrev.2012.06.002. Epub 2012 Aug 4.

Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano
P, Valgimigli M, Jegere S, Makkar RR, Palacios IF,
Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran
R, Naber C, Margey R, Agnihotri A, Marra S, Capodanno
D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC,
Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
Drug-eluting stent for left main coronary artery disease.
The DELTA registry: a multicenter registry evaluating
percutaneous coronary intervention versus coronary artery
bypass grafting for left main treatment.
JACC Cardiovasc Interv. 2012 Jul;5(7):718-27. doi:
10.1016/j.jcin.2012.03.022.

Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler
G, Sievert H, Naber C, Voehringer M, Schäfer U, Senges
J, Richardt G.
Transcatheter aortic valve implantation in patients with
and without concomitant coronary artery disease: comparison
of characteristics and early outcome in the German
multicenter TAVI registry.
Clin Res Cardiol. 2012 Dec;101(12):973-81. doi: 10.1007/
s00392-012-0486-5. Epub 2012 Jul

Naber CK, Sachdev B, Muller O, Eeckhout E, Fajadet J.
Tools & Techniques: the year of the Textbook - time to
say good-bye!
EuroIntervention. 2012 May 15;8(1):164-5. doi: 10.4244/
EIJV8I1A24. No abstract available.

Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber
C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-
Mangoni E, Spelman D, Hoen B, Lejko-Zupanc T, Cecchi
E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG Jr,
Crowley AL, Wang A; ICE-PCS Investigators.
Clinical characteristics and outcome of infective endocarditis
involving implantable cardiac devices.
JAMA. 2012 Apr 25;307(16):1727-35. doi: 10.1001/
jama.2012.497.

Naber CK, Prendergast B, Thomas M, Vahanian A, Iung B,
Rosenhek R, Tornos P, Otto CM, Antunes MJ, Kappetein P,
Lange R, Wendler O.
An interdisciplinary debate initiated by the European
Society of Cardiology Working Group on Valvular Heart
Disease.
EuroIntervention. 2012 Mar;7(11):1257-74. doi: 10.4244/
EIJV7I11A201. No abstract available.

Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber
C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P.
A multicenter randomized comparison of drug-eluting
balloon plus bare-metal stent versus bare-metal stent
versus drug-eluting stent in bifurcation lesions treated
with a single-stenting technique: six-month angiographic
and 12-month clinical results of the drug-eluting
balloon in bifurcations trial.
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46.
doi: 10.1002/ccd.23499. Epub 2012 Mar 15.

Naber CK, Ghanem A, Abizaid AA, Wolf A, Sinning JM,
Werner N, Nickenig G, Schmitz T, Grube E.
First-in-man use of a novel embolic protection device
for patients undergoing transcatheter aortic valve implantation.
EuroIntervention. 2012 May 15;8(1):43-50. doi: 10.4244/
EIJV8I1A8.

Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour
LM, Danik SB, Peacock J, Falces C, Miro JM, Blank E,
Naber C, Carrillo RG, Tseng CH, Uslan DZ.
Timing of the most recent device procedure influences
the clinical outcome of lead-associated endocarditis
results of the MEDIC (Multicenter Electrophysiologic
Device Infection Cohort).
J Am Coll Cardiol. 2012 Feb 14;59(7):681-7. doi: 10.1016/j.
jacc.2011.11.011.

Jeger R, Pfisterer M, Alber H, Eberli F, Galatius S, Naber C,
Pedrazzini G, Rickli H, Jensen JS, Vuilliomenet A, Gilgen
N, Kaiser C.
Newest-generation drug-eluting and bare-metal stents
combined with prasugrel-based antiplatelet therapy in
large coronary arteries: the BAsel Stent Kosten Effektivitäts
Trial PROspective Validation Examination part II 
(BASKET-PROVE II) trial design.
Am Heart J. 2012 Feb;163(2):136-41.e1. doi: 10.1016/j.
ahj.2011.08.023.

Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast
BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber
CK, Acartürk E, Gohlke-Bärwolf C.
ESC Working Group on Valvular Heart Disease Position
Paper: assessing the risk of interventions in patients
with valvular heart disease.
Eur Heart J. 2012 Apr;33(7):822-8, 828a, 828b. doi:
10.1093/eurheartj/ehr061. Epub 2011 Mar 15.

Li J, Becker R, Rauch B, Schiele R, Schneider S, Riemer T,
Diller F, Gohlke H, Gottwik M, Steinbeck G, Sabin G, Katus
HA, Senges J; OMEGA Study Group.
Usefulness of Heart Rate to Predict One-Year Mortality
in Patients With Atrial Fibrillation and Acute Myocardial
Infarction (from the OMEGA Trial).
Am J Cardiol. 2012 Dec 28. doi:pii: S0002-9149(12)02482-
4. 10.1016/j.amjcard.2012.11.048. [Epub ahead of print]

Zahn R, Neumann FJ, Büttner HJ, Richardt G, Schneider S,
Levenson B, Tebbe U, Sabin G, Nienaber CA, Pfannebecker
T, Hamm CW.
Long-term follow-up after coronary stenting with the
sirolimus-eluting stent in clinical practice: results from
the prospective multi-center German Cypher Stent Registry.
Clin Res Cardiol. 2012 Sep;101(9):709-16. doi: 10.1007/
s00392-012-0448-y. Epub 2012 Apr

Abdel-Wahab M, Nienaber CA, Mostafa AE, Ferenc M,
Silber S, Sabin G, Tebbe U, Akin I, Hochadel M, Senges J,
Kuck KH, Richardt G; German Drug-Eluting Stent (DES.
DE) Registry.
Treatment of coronary bifurcation lesions with drugeluting
stents: insights from the first phase of the prospective
multicenter german drug-eluting stent registry.
J Interv Cardiol. 2012 Aug;25(4):344-52. doi:
10.1111/j.1540-8183.2011.00718.x. Epub 2012 Mar 12.

Wieneke H, Rickers S, Velleuer J, Bruck G, Bai Z, Kocks
C, Grandjean PA, Lenihan T, Jung P, Erbel R, Prinzen FW,
Kisker E.
Leadless pacing using induction technology: impact of
pulse shape and geometric factors on pacing efficiency.
Europace. 2012 Oct 1. [Epub ahead of print]

I. Voigt, C. K. Naber
Bleeding complications of percutaneous dilatation tracheostomy
(PDT) in a group of ICU patients with dual antiplatelet therapy
Crit Care & Shock. 01/2012; 15(1):70-76.

John D. Grizzard, Christoph J. Jensen, Raymond J. Kim
Problem Solving in Radiology, 1st Edition. Chapter 28:
Myocardial Ischemic Disease- Magnetic Resonance Imaging.
Editor: S. Abbara and S. Kalva, Elsevier. ISBN:
9781437727685.